Siga Technologies (SIGA) Cash from Operations (2010 - 2025)
Siga Technologies' (SIGA) quarterly Cash from Operations came in at -$9.8 million in Q3 2025, down 32.92% on a YoY basis from -$14.6 million in Q3 2024, and down 115.56% quarter-over-quarter from $63.1 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Cash from Operations (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Cash from Operations for 16 consecutive years, with -$9.8 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Cash from Operations fell 32.92% year-over-year to -$9.8 million; the trailing twelve-month figure through Sep 2025 stood at $116.6 million (up 63.17% YoY), and the FY2024 full-year result was $48.8 million, down 48.56% from the prior year.
- Cash from Operations eased to -$9.8 million in Q3 2025 per SIGA's latest filing, from $63.1 million in the prior quarter.
- Across five years, Cash from Operations topped out at $79.0 million in Q4 2023 and bottomed at -$9.8 million in Q3 2025.
- Historically, Cash from Operations has averaged $13.5 million across 5 years, with a median of -$1.4 million in 2021.
- The widest YoY moves for Cash from Operations: up 1279.83% in 2022, down 393.58% in 2022.
- Over 5 years, Cash from Operations stood at $16.1 million in 2021, then plunged by 150.34% to -$8.1 million in 2022, then surged by 1074.95% to $79.0 million in 2023, then decreased by 28.75% to $56.3 million in 2024, then plunged by 117.43% to -$9.8 million in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered -$9.8 million, $63.1 million, and $7.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 835.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -387.32 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 507.66 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 313.60 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -9.81 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Mar 31, 2025 | 7.06 Mn |
| Dec 31, 2024 | 56.31 Mn |
| Sep 30, 2024 | -7.38 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -3.58 Mn |
| Mar 31, 2023 | 24.45 Mn |
| Dec 31, 2022 | -8.11 Mn |
| Sep 30, 2022 | -4.78 Mn |
| Jun 30, 2022 | -2.21 Mn |
| Mar 31, 2022 | 56.71 Mn |
| Dec 31, 2021 | 16.10 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | -1.43 Mn |
| Mar 31, 2021 | -4.81 Mn |
| Dec 31, 2020 | 45.95 Mn |